{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Manso BA"],"funding":["NICHD NIH HHS","NIA NIH HHS","NIGMS NIH HHS"],"pubmed_abstract":["Distinct routes of cellular production from hematopoietic stem cells (HSCs) have defined our current view of hematopoiesis. Recently, we challenged classical views of platelet generation, demonstrating that megakaryocyte progenitors (MkPs), and ultimately platelets, can be specified via an alternate and additive route of HSC-direct specification specifically during aging. This \"shortcut\" pathway generates hyperactive platelets likely to contribute to age-related platelet-mediated morbidities. Here, we used single-cell RNA/CITEseq to demonstrate that these age-unique, non-canonical (nc)MkPs can be prospectively defined and experimentally isolated from wild type mice. Surprisingly, this revealed that a rare population of ncMkPs also exist in young mice. Young and aged ncMkPs are functionally distinct from their canonical (c)MkP counterparts, with aged ncMkPs paradoxically and uniquely exhibiting enhanced survival and platelet generation capacity. We further demonstrate that aged HSCs generate significantly more ncMkPs than their younger counterparts, yet this is accomplished without strict clonal restriction. Together, these findings reveal significant phenotypic, functional, and aging-dependent heterogeneity among the MkP pool and uncover unique features of megakaryopoiesis throughout life, potentially offering cellular and molecular targets for mitigation of age-related adverse thrombotic events."],"journal":["bioRxiv : the preprint server for biology"],"pagination":["2024.11.04.621964"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11580903"],"repository":["biostudies-literature"],"pubmed_title":["A rare HSC-derived megakaryocyte progenitor accumulates via enhanced survival and contributes to exacerbated thrombopoiesis upon aging."],"pmcid":["PMC11580903"],"funding_grant_id":["K12 GM139185","R01 AG062879","T32 HD108079","R25 GM104552"],"pubmed_authors":["Deguzman A","Avila SB","Mok L","Baena ARY","Jonsson VD","Smith-Berdan S","Bachinsky E","Manso BA","Rommel MGE","Chattopadhyaya S","Medina P","Forsberg EC"],"additional_accession":[]},"is_claimable":false,"name":"A rare HSC-derived megakaryocyte progenitor accumulates via enhanced survival and contributes to exacerbated thrombopoiesis upon aging.","description":"Distinct routes of cellular production from hematopoietic stem cells (HSCs) have defined our current view of hematopoiesis. Recently, we challenged classical views of platelet generation, demonstrating that megakaryocyte progenitors (MkPs), and ultimately platelets, can be specified via an alternate and additive route of HSC-direct specification specifically during aging. This \"shortcut\" pathway generates hyperactive platelets likely to contribute to age-related platelet-mediated morbidities. Here, we used single-cell RNA/CITEseq to demonstrate that these age-unique, non-canonical (nc)MkPs can be prospectively defined and experimentally isolated from wild type mice. Surprisingly, this revealed that a rare population of ncMkPs also exist in young mice. Young and aged ncMkPs are functionally distinct from their canonical (c)MkP counterparts, with aged ncMkPs paradoxically and uniquely exhibiting enhanced survival and platelet generation capacity. We further demonstrate that aged HSCs generate significantly more ncMkPs than their younger counterparts, yet this is accomplished without strict clonal restriction. Together, these findings reveal significant phenotypic, functional, and aging-dependent heterogeneity among the MkP pool and uncover unique features of megakaryopoiesis throughout life, potentially offering cellular and molecular targets for mitigation of age-related adverse thrombotic events.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-05-31T03:10:44.786Z","creation":"2026-05-31T03:06:46.895Z"},"accession":"S-EPMC11580903","cross_references":{"pubmed":["39574585"],"doi":["10.1101/2024.11.04.621964"]}}